Differential properties of mitosis-associated events following CHK1 and WEE1 inhibitor treatments in human tongue carcinoma cells.


Journal

Experimental cell research
ISSN: 1090-2422
Titre abrégé: Exp Cell Res
Pays: United States
ID NLM: 0373226

Informations de publication

Date de publication:
15 01 2020
Historique:
received: 28 09 2019
revised: 08 11 2019
accepted: 10 11 2019
pubmed: 19 11 2019
medline: 17 7 2020
entrez: 19 11 2019
Statut: ppublish

Résumé

CHK1 and WEE1 play pivotal roles in G2/M checkpoint following exogenous DNA damage and regulation of DNA replication under normal cellular conditions. Here, we monitored and compared the cell cycle kinetics of mitosis-associated events after CHK1 and WEE1 inhibitor treatments in a human tongue cancer cell line (SAS). A fluorescent ubiquitination-based cell cycle indicator (Fucci) that reflects SCF

Identifiants

pubmed: 31738907
pii: S0014-4827(19)30599-3
doi: 10.1016/j.yexcr.2019.111720
pii:
doi:

Substances chimiques

Cdh1 Proteins 0
Cell Cycle Proteins 0
H2AX protein, human 0
Histones 0
Protein Kinase Inhibitors 0
S-Phase Kinase-Associated Proteins 0
Protein-Tyrosine Kinases EC 2.7.10.1
WEE1 protein, human EC 2.7.10.2
CHEK1 protein, human EC 2.7.11.1
Checkpoint Kinase 1 EC 2.7.11.1
Protein Serine-Threonine Kinases EC 2.7.11.1
TTK protein, human EC 2.7.12.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

111720

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Hitomi Nojima (H)

Department of Oral Radiation Oncology, Division of Oral Health Sciences, Graduate School of Medical and Dental Sciences, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8549, Japan; Department of Oral and Maxillofacial Surgery, Division of Oral Health Sciences, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8549, Japan.

Hisao Homma (H)

Department of Oral Radiation Oncology, Division of Oral Health Sciences, Graduate School of Medical and Dental Sciences, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8549, Japan.

Yusuke Onozato (Y)

Department of Oral Radiation Oncology, Division of Oral Health Sciences, Graduate School of Medical and Dental Sciences, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8549, Japan.

Atsushi Kaida (A)

Department of Oral Radiation Oncology, Division of Oral Health Sciences, Graduate School of Medical and Dental Sciences, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8549, Japan.

Hiroyuki Harada (H)

Department of Oral and Maxillofacial Surgery, Division of Oral Health Sciences, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8549, Japan.

Masahiko Miura (M)

Department of Oral Radiation Oncology, Division of Oral Health Sciences, Graduate School of Medical and Dental Sciences, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8549, Japan. Electronic address: masa.mdth@tmd.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH